* AxoGen Inc AXGN.OQ AXGN.O is expected to show a rise
in
quarterly revenue when it reports results on August 8 for the
period ending June 30 2024
* The Alachua Florida-based company is expected to report a
13.7% increase in revenue to $43.391 million from $38.16 million
a year ago, according to the mean estimate from 7 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for AxoGen Inc is for a loss
of 4
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for AxoGen Inc
is
$13.00, above its last closing price of $7.80.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 -0.04 -0.07 -0.06 Beat 11.8
Dec. 31 2024 -0.12 -0.06 37.8
Sep. 30 2023 -0.05 -0.06 0.01 Beat 116
Jun. 30 2023 -0.11 -0.13 -0.03 Beat 76.9
Jan. -0.15 -0.14 -0.10 Beat 31
1 0001
Dec. 31 2022 -0.11 -0.11 -0.03 Beat 73.6
Sep. 30 2022 -0.13 -0.12 -0.01 Beat 91.8
Jun. 30 2022 -0.14 -0.14 -0.06 Beat 58.6
This summary was machine generated August 6 at 18:56 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)